Israel · Delayed Price · Currency is ILS · Price in ILA Univo Pharmaceuticals Statistics
Total Valuation
TLV:UNVO.M has a market cap or net worth of ILS 76.
| Market Cap | 76 |
| Enterprise Value | n/a |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
TLV:UNVO.M has 3,056 shares outstanding.
| Current Share Class | 3,056 |
| Shares Outstanding | 3,056 |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 0.00 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.33, with a Debt / Equity ratio of 2.05.
| Current Ratio | 1.33 |
| Quick Ratio | 0.61 |
| Debt / Equity | 2.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -14.66 |
Financial Efficiency
Return on equity (ROE) is -105.36% and return on invested capital (ROIC) is -27.12%.
| Return on Equity (ROE) | -105.36% |
| Return on Assets (ROA) | -21.99% |
| Return on Invested Capital (ROIC) | -27.12% |
| Return on Capital Employed (ROCE) | -57.65% |
| Weighted Average Cost of Capital (WACC) | 3.71% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 76 |
| Asset Turnover | 0.53 |
| Inventory Turnover | 4.86 |
Taxes
| Income Tax | -998,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | 0.68 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | 34 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TLV:UNVO.M had revenue of ILS 43.89 million and -32.19 million in losses.
| Revenue | 43.89M |
| Gross Profit | 639,000 |
| Operating Income | -28.92M |
| Pretax Income | -33.64M |
| Net Income | -32.19M |
| EBITDA | -26.04M |
| EBIT | -28.92M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 4.50 million in cash and 41.98 million in debt, with a net cash position of -37.48 million or -12,264.07 per share.
| Cash & Cash Equivalents | 4.50M |
| Total Debt | 41.98M |
| Net Cash | -37.48M |
| Net Cash Per Share | -12,264.07 |
| Equity (Book Value) | 20.50M |
| Book Value Per Share | n/a |
| Working Capital | 8.49M |
Cash Flow
In the last 12 months, operating cash flow was -16.02 million and capital expenditures -4.17 million, giving a free cash flow of -20.19 million.
| Operating Cash Flow | -16.02M |
| Capital Expenditures | -4.17M |
| Depreciation & Amortization | 2.89M |
| Net Borrowing | 9.96M |
| Free Cash Flow | -20.19M |
| FCF Per Share | -6,605.69 |
Margins
Gross margin is 1.46%, with operating and profit margins of -65.89% and -73.35%.
| Gross Margin | 1.46% |
| Operating Margin | -65.89% |
| Pretax Margin | -76.63% |
| Profit Margin | -73.35% |
| EBITDA Margin | -59.31% |
| EBIT Margin | -65.89% |
| FCF Margin | n/a |
Dividends & Yields
TLV:UNVO.M does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -42,360,526.32% |
| FCF Yield | -26,561,842.11% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on December 16, 2025. It was a reverse split with a ratio of 0.1.
| Last Split Date | Dec 16, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
TLV:UNVO.M has an Altman Z-Score of -1.78 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.78 |
| Piotroski F-Score | 1 |